TransCode Therapeutics Inc. (RNAZ)

Last Closing Price: 8.80 (2026-04-17)

Revenue (Quarterly)

Revenue: The sum of all revenue fields included for a company's operating activities.

TransCode Therapeutics Inc. (RNAZ) Revenue data is not available.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
Revenue
--
$-15.05M
--
--
$16.03M
$-16.03M
$2.81M
$-13.22M
$-13.22M
$-13.44M
$-13.44M
$-13.44M
$-13.44M
$-16.03M
$-15.98M
0.69M
0.69M
$28.67
$28.67
Balance Sheet Financials
$21.98M
$0.37M
$140.41M
$162.40M
$3.49M
--
$148.57M
$152.06M
$10.34M
$-129.71M
$10.34M
0.92M
Cash Flow Statement Financials
$-19.52M
$-0.00M
$31.52M
$5.81M
$17.81M
$12.00M
$0.49M
--
--
Fundamental Metrics & Ratios
6.29
--
--
--
--
--
--
--
--
--
--
$-19.52M
--
--
--
--
--
--
--
-130.07%
10.36%
-8.28%
-130.07%
$11.27
$-28.31
$-28.30